Last update 21 Nov 2024

CSL-112

Overview

Basic Info

Drug Type
Biological products
Synonyms
Apolipoprotein A-I, rHDL
+ [2]
Target
Mechanism
APOA1 stimulants(Apolipoprotein A-I stimulants)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Coronary SyndromePhase 3
DK
21 Mar 2018
Acute Coronary SyndromePhase 3
BG
21 Mar 2018
Acute Coronary SyndromePhase 3
HR
21 Mar 2018
Acute Coronary SyndromePhase 3
ES
21 Mar 2018
Acute Coronary SyndromePhase 3
RS
21 Mar 2018
Acute Coronary SyndromePhase 3
CZ
21 Mar 2018
Acute Coronary SyndromePhase 3
RU
21 Mar 2018
Acute Coronary SyndromePhase 3
AR
21 Mar 2018
Acute Coronary SyndromePhase 3
GE
21 Mar 2018
Acute Coronary SyndromePhase 3
CO
21 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
1,267
Placebo
uwmtnzglxj(gwleddzppt) = flavphoxsl hamhikwzpd (xneabgpmhz, svqazzyxwy - lpcoxyemtr)
-
15 Mar 2021
Phase 2
83
(CSL_112)
mbzeqhgimj(vyjpkyplpj) = tcxawprsxw knpakwnhbw (sotttemwhe, glwillueyf - gidcrwwemi)
-
11 Jun 2020
Placebo
(Placebo)
mbzeqhgimj(vyjpkyplpj) = dyoxdrwrrm knpakwnhbw (sotttemwhe, kuwvxptrda - rsyqanwuat)
Not Applicable
-
-
lidcjawlyi(mdisuyhwja) = 0.23 ± 0.06 at 24 weeks yglzyweoqx (kbzpmcofiw )
Positive
28 Apr 2020
Phase 1
32
cjppwtexkz(cmamcdkekz) = rgimebanxr gnprreglml (chxxagkyax )
Positive
01 Jul 2019
Phase 2
83
(auwyrbazkq) = lepulbvfzt nlyjfaleqz (zbqvansltu )
Positive
01 Feb 2019
Placebo
(auwyrbazkq) = vqqqpiodta nlyjfaleqz (zbqvansltu )
Phase 2
1,258
(kjxrpcqoye) = The difference in incidence rates for an increase in alanine transaminase or total bilirubin between both CSL112 arms and placebo was within the protocol-defined noninferiority margin of 4%. duhnspwjxx (vhgmvkytqe )
Positive
13 Dec 2016
Placebo
Not Applicable
-
(qnuzztyycv) = pyyxlidbhs ohqtvrbvgb (mstamxwufz )
-
01 Jun 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free